Kim Bure

Latest from Kim Bure

Quality By Design for Advanced Therapies: An Informed Route to Enhanced Late-Stage Clinical Success and Empowered Process Flexibility
Cell Therapies
Quality By Design for Advanced Therapies: An Informed Route to Enhanced Late-Stage Clinical Success and Empowered Process FlexibilityQuality By Design for Advanced Therapies: An Informed Route to Enhanced Late-Stage Clinical Success and Empowered Process Flexibility
byKim Bure, Yonatan Lipsitzand 3 more
May 24, 2020
Scalable Purification of Viral Vectors for Gene Therapy: An Appraisal of Downstream Processing Approaches
Separation/Purification
Scalable Purification of Viral Vectors for Gene Therapy: An Appraisal of Downstream Processing ApproachesScalable Purification of Viral Vectors for Gene Therapy: An Appraisal of Downstream Processing Approaches
byMaya Fuerstenau-Sharp, David Pettittand 4 more
Feb 13, 2017

All from Kim Bure

Emerging Platform Bioprocesses for Viral Vectors and Gene Therapies
Emerging Therapeutics
Emerging Platform Bioprocesses for Viral Vectors and Gene Therapies
Emerging Platform Bioprocesses for Viral Vectors and Gene Therapies
Apr 18, 2016
+8
byDavid A. Brindley, Maya Fuerstenau-Sharpand 8 more
Automation of CAR-T Cell Adoptive Immunotherapy Bioprocessing: Technology Opportunities to Debottleneck Manufacturing
Personalized Medicine
Automation of CAR-T Cell Adoptive Immunotherapy Bioprocessing: Technology Opportunities to Debottleneck Manufacturing
Automation of CAR-T Cell Adoptive Immunotherapy Bioprocessing: Technology Opportunities to Debottleneck Manufacturing
Apr 18, 2016
+11
byDavid A. Brindley, James A. Smithand 11 more
Therapeutic Gene Editing: Tools to Facilitate Basic Science or Stimuli for a Paradigm Shift in Biomanufacturing?
Personalized Medicine
Therapeutic Gene Editing: Tools to Facilitate Basic Science or Stimuli for a Paradigm Shift in Biomanufacturing?
Therapeutic Gene Editing: Tools to Facilitate Basic Science or Stimuli for a Paradigm Shift in Biomanufacturing?
Apr 18, 2016
+3
byEric Roos, James A. Smithand 3 more
Decision-Support Tools for Monoclonal Antibody and Cell Therapy Bioprocessing: Current Landscape and Development Opportunities
MAb
Decision-Support Tools for Monoclonal Antibody and Cell Therapy Bioprocessing: Current Landscape and Development Opportunities
Decision-Support Tools for Monoclonal Antibody and Cell Therapy Bioprocessing: Current Landscape and Development Opportunities
Dec 16, 2015
+6
byRahul Rekhi, James A. Smithand 6 more
Quantitative Risk Assessment of Bioaccumulation Attributable to Extractables and Leachables in Cellular Immunotherapy Biomanufacturing
Cell Therapies
Quantitative Risk Assessment of Bioaccumulation Attributable to Extractables and Leachables in Cellular Immunotherapy Biomanufacturing
Quantitative Risk Assessment of Bioaccumulation Attributable to Extractables and Leachables in Cellular Immunotherapy Biomanufacturing
Nov 16, 2015
+2
byKevin Lannon, James A. Smithand 2 more
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
Cell Therapies
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
Apr 15, 2015
+9
byJames A. Smith, Kelvin S. Ngand 9 more
The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies logo in a gray background | The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies
Cell Therapies
The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies
The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies
Apr 15, 2015
+7
byDavid A. Brindley, Rahul Rekhiand 7 more
Tabular Data for "Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence" logo in a gray background | Tabular Data for "Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence"
Business
Tabular Data for "Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence"
Tabular Data for "Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence"
Mar 1, 2014
+5
byDavid A. Brindley, Anna L. Frenchand 5 more
Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence logo in a gray background | Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence
Cell Culture Media
Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence
Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence
Mar 1, 2014
+5
byDavid A. Brindley, Anna L. Frenchand 5 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024